Related Experiment Videos
Pseudomonas exotoxin and recombinant immunotoxins derived from it
1Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.
Annals of the New York Academy of Sciences
|June 23, 1993
Summary
Pseudomonas exotoxin (PE) kills mammalian cells by entering the cytosol and stopping protein synthesis. Modified PE toxins are being developed as potential therapies for diseases like cancer and AIDS.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Pseudomonas exotoxin (PE) is a potent bacterial toxin.
- PE targets mammalian cells by inhibiting protein synthesis.
- Cellular entry is mediated by alpha 2-macroglobulin receptors.
Purpose of the Study:
- To investigate the mechanism of Pseudomonas exotoxin action.
- To explore the potential of PE derivatives as therapeutic agents.
Main Methods:
- Analysis of PE entry and processing pathways.
- Characterization of the enzymatically active fragment of PE.
- Development of PE-ligand conjugates for targeted cell killing.
Main Results:
- PE enters cells via alpha 2-macroglobulin receptors.
- A 37-kDa C-terminal fragment translocates to the cytosol.
- This fragment inactivates protein synthesis by ADP-ribosylating elongation factor 2.
Conclusions:
- Pseudomonas exotoxin's mechanism involves cytosolic delivery and protein synthesis inhibition.
- Engineered PE derivatives show promise for targeted cancer and AIDS therapy.